Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) fell 0% during trading on Wednesday . The stock traded as low as $4.8942 and last traded at $4.9190. 47,127 shares changed hands during mid-day trading, an increase of 80% from the average session volume of 26,172 shares. The stock had previously closed at $4.92.
Ono Pharmaceutical Stock Down 0.0%
The firm’s fifty day moving average price is $5.08 and its 200 day moving average price is $4.91.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.
Further Reading
- Five stocks we like better than Ono Pharmaceutical
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
